Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: ACS Appl Mater Interfaces. 2013 Aug 28;5(17):8283–8288. doi: 10.1021/am402594z

Scheme 1.

Scheme 1

(A) Structure of BFDMA, a redox-active ferrocenyl lipid. (B-C) Schematic illustration demonstrating core principles: (B) Lipoplexes of oxidized BFDMA (gray) are inactive and can be distributed uniformly over cells without promoting transfection. (C) Controlled administration of soluble or solid-phase reducing agents results in localized activation of lipoplexes (red) and spatially controlled transfection (green); adjacent cells are unaffected.